These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18765282)

  • 1. Alternative matrix formers for nanosuspension solidification: Dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion.
    Van Eerdenbrugh B; Froyen L; Van Humbeeck J; Martens JA; Augustijns P; Van Den Mooter G
    Eur J Pharm Sci; 2008 Nov; 35(4):344-53. PubMed ID: 18765282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
    Mou D; Chen H; Wan J; Xu H; Yang X
    Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.
    Van Eerdenbrugh B; Froyen L; Van Humbeeck J; Martens JA; Augustijns P; Van den Mooter G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):127-35. PubMed ID: 18644441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization.
    Ye G; Wang S; Heng PW; Chen L; Wang C
    Int J Pharm; 2007 Jun; 337(1-2):80-7. PubMed ID: 17241757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and drying of miconazole and itraconazole nanosuspensions.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.
    Overhoff KA; Moreno A; Miller DA; Johnston KP; Williams RO
    Int J Pharm; 2007 May; 336(1):122-32. PubMed ID: 17184938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryogenic liquids, nanoparticles, and microencapsulation.
    Purvis T; Vaughn JM; Rogers TL; Chen X; Overhoff KA; Sinswat P; Hu J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2006 Oct; 324(1):43-50. PubMed ID: 16814968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole.
    Van Eerdenbrugh B; Vercruysse S; Martens JA; Vermant J; Froyen L; Van Humbeeck J; Van den Mooter G; Augustijns P
    Eur J Pharm Biopharm; 2008 Oct; 70(2):590-6. PubMed ID: 18602992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
    Tao T; Zhao Y; Wu J; Zhou B
    Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downstream processing of a ternary amorphous solid dispersion: The impacts of spray drying and hot melt extrusion on powder flow, compression and dissolution.
    Davis MT; Potter CB; Walker GM
    Int J Pharm; 2018 Jun; 544(1):242-253. PubMed ID: 29689366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
    Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
    Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanonized itraconazole powders for extemporary oral suspensions: Role of formulation components studied by a mixture design.
    Foglio Bonda A; Rinaldi M; Segale L; Palugan L; Cerea M; Vecchio C; Pattarino F
    Eur J Pharm Sci; 2016 Feb; 83():175-83. PubMed ID: 26742430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of nanosuspensions into dry powders by spray drying: a case study.
    Chaubal MV; Popescu C
    Pharm Res; 2008 Oct; 25(10):2302-8. PubMed ID: 18509597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole.
    Jung H; Kim HM; Choy YB; Hwang SJ; Choy JH
    Int J Pharm; 2008 Feb; 349(1-2):283-90. PubMed ID: 17888597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
    Kocbek P; Baumgartner S; Kristl J
    Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole.
    Kumar S; Shen J; Burgess DJ
    J Control Release; 2014 Oct; 192():95-102. PubMed ID: 25009979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilizer choice for rapid dissolving high potency itraconazole particles formed by evaporative precipitation into aqueous solution.
    Sinswat P; Gao X; Yacaman MJ; Williams RO; Johnston KP
    Int J Pharm; 2005 Sep; 302(1-2):113-24. PubMed ID: 16109466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.